Last reviewed · How we verify
CRTE7A2-01 TCR-T cell therapy
CRTE7A2-01 TCR-T cell therapy is a Small molecule drug developed by Corregene Biotechnology Co., Ltd. It is currently in Phase 1 development. Also known as: CRTE7A2.
At a glance
| Generic name | CRTE7A2-01 TCR-T cell therapy |
|---|---|
| Also known as | CRTE7A2 |
| Sponsor | Corregene Biotechnology Co., Ltd |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers (PHASE1)
- CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CRTE7A2-01 TCR-T cell therapy CI brief — competitive landscape report
- CRTE7A2-01 TCR-T cell therapy updates RSS · CI watch RSS
- Corregene Biotechnology Co., Ltd portfolio CI
Frequently asked questions about CRTE7A2-01 TCR-T cell therapy
What is CRTE7A2-01 TCR-T cell therapy?
CRTE7A2-01 TCR-T cell therapy is a Small molecule drug developed by Corregene Biotechnology Co., Ltd.
Who makes CRTE7A2-01 TCR-T cell therapy?
CRTE7A2-01 TCR-T cell therapy is developed by Corregene Biotechnology Co., Ltd (see full Corregene Biotechnology Co., Ltd pipeline at /company/corregene-biotechnology-co-ltd).
Is CRTE7A2-01 TCR-T cell therapy also known as anything else?
CRTE7A2-01 TCR-T cell therapy is also known as CRTE7A2.
What development phase is CRTE7A2-01 TCR-T cell therapy in?
CRTE7A2-01 TCR-T cell therapy is in Phase 1.
Related
- Manufacturer: Corregene Biotechnology Co., Ltd — full pipeline
- Also known as: CRTE7A2
- Compare: CRTE7A2-01 TCR-T cell therapy vs similar drugs
- Pricing: CRTE7A2-01 TCR-T cell therapy cost, discount & access